Introduction. Transarterial chemoembolization is the first-line treatment in unresectable @entity157 . There is no standard treatment after transarterial chemoembolization failure. We report the case of a @entity1 with advanced @entity157 who showed a complete response and a long @entity5 control with hypofractionated stereotactic radiotherapy after transarterial chemoembolization failure. Case Presentation. A 70-year-old Caucasian @entity1 was treated with transarterial chemoembolization for advanced hepatocellular, but no @entity5 control was obtained. A hypofractionated stereotactic radiotherapy was planned delivering 40   Gy in 5 fractions. A dramatic reduction in @entity160 was observed. Contrast-enhanced ultrasonography at 1 and 2 months showed large @entity39 areas. Computerised tomography scan showed a 90% objective @entity5 response, then a complete remission at 3 and 6 months after treatment, respectively. Status of @entity1 remained unchanged for 2 years. Conclusions. Hypofractionated stereotactic radiotherapy can improve survival and prognosis of unresectable @entity157 @entity1 .

Hypofractionated stereotactic radiotherapy after transarterial chemoembolisation failure in an unresectable XXXX : a case presentation.

@entity1 :: ('9606', 'Species') :: ['woman', 'patient'] @entity39 :: ('MESH:D009336', 'Disease') :: ['necrotic'] @entity5 :: ('MESH:D009369', 'Disease') :: ['cancer', 'tumour'] @entity160 :: ('174', 'Gene') :: ['alpha-fetoprotein'] @entity157 :: ('MESH:D006528', 'Disease') :: ['hepatocellular carcinoma']
@entity157 :: (MESH:D006528,Disease) :: ['hepatocellular carcinoma']
